AstraZeneca's COVID-19 vaccine trial remains on hold in the United States pending a U.S. investigation into a serious side effect in Britain even as other trials of the vaccine resume, sources familiar with the details told Reuters.
COVID-19 vaccine trial remains on hold in the United States pending a U.S. investigation into a serious side effect in Britain even as other trials of the vaccine resume, sources familiar with the details told Reuters.
AstraZeneca on Saturday said it had restarted its trial in Britain after regulators completed their review of a serious side effect in one trial participant there. Enrollment in the company’s global trials of the vaccine, which it is developing with researchers at Oxford University, was put on pause on Sept. 6.
The British adverse event involved a study patient thought to be suffering a rare spinal inflammatory disorder called transverse myelitis.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Exclusive: AstraZeneca COVID-19 vaccine trial in U.S. on hold until at least midweek - sourcesAstraZeneca's COVID-19 vaccine trial remains on hold in the United States pending a U.S. investigation into a serious side effect in Britain even as other trials of the vaccine resume, sources familiar with the details told Reuters.
Weiterlesen »
Some volunteers quit J&J COVID-19 trial in Spain after AstraZeneca scare, investigator saysSome volunteers have quit Johnson & Johnson's COVID-19 vaccine trial in Spain after news of side effects in a participant in AstraZeneca's trial, the Spanish programme's lead investigator told Reuters on Tuesday.
Weiterlesen »
WHO praises AstraZeneca COVID-19 vaccine trial pauseA World Health Organization official on Tuesday said that the decision by AstraZeneca to pause global trials of its experimental coronavirus vaccine after an unexplained illness showed the firm was prioritising safety.
Weiterlesen »
AstraZeneca resumes COVID-19 vaccine trials in South Africa, health dept saysAstraZeneca has resumed COVID-19 vaccine trials in South Africa, more than a week after tests were paused due to serious side effects in a participant in Britain, an official at the country's Department of Health told Reuters on Tuesday.
Weiterlesen »
AstraZeneca COVID-19 vaccine trials resume in BrazilClinical trials for the coronavirus vaccine being developed by AstraZeneca PLC and Oxford University resumed in Brazil on Monday after the country's health regulator got confirmation over the weekend that its British equivalent MHRA had approved the restart, a company representative...
Weiterlesen »
WSJ News Exclusive | Hospitals Failed to Fully Contain Covid-19 Inside Their WallsAn average of 120 patients a day became infected with the new coronavirus inside U.S. hospitals as the pandemic ebbed from its spring peak and rebounded into the summer, according to CDC data provided to The Wall Street Journal.
Weiterlesen »